Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Epilepsy & Behavior : E&B|August 27, 2020
Psychosocial impact on siblings of patients with developmental and epileptic encephalopathiesLaurie D Bailey, Lauren Schwartz, Tracy Dixon-Salazar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 6, 2020
Development and validation of the University of Washington caregiver stress and benefit scales for caregivers of children with or without serious health conditionsDagmar Amtmann, Kendra S Liljenquist, Alyssa Bamer, et al.
Epilepsy & Behavior : E&B|April 22, 2017
The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future researchMark P Jensen, Andreas Brunklaus, Liam Dorris, et al.
Pain Medicine (Malden, Mass.)|July 5, 2012
Predicting response to pregabalin from pretreatment pain quality: clinical applications of the pain quality assessment scaleArnold R Gammaitoni, Steven S Smugar, Mark P Jensen, et al.
The Clinical Journal of Pain|December 14, 2011
The pain quality response profile of pregabalin in the treatment of neuropathic painMark P Jensen, Arnold R Gammaitoni, James A Bolognese, et al.
Arthritis Care & Research|January 13, 2015
Characterizing Pain Flares From the Perspective of Individuals With Symptomatic Knee OsteoarthritisSusan L Murphy, Angela K Lyden, Anna L Kratz, et al.
Epilepsia|October 22, 2021
Fenfluramine significantly reduces day-to-day seizure burden by increasing number of seizure-free days and time between seizures in patients with Dravet syndrome: A time-to-event analysisJoseph Sullivan, Nicola Specchio, Orrin Devinsky, et al.
Epilepsy & Behavior : E&B|May 23, 2021
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndromeKim I Bishop, Peter K Isquith, Gerard A Gioia, et al.
International Journal of Rheumatic Diseases|June 12, 2010
Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trialHsiao-Yi Lin, Tien-Tsai Cheng, Jyh-Horng Wang, et al.
Seizure|November 12, 2021
Impact of fenfluramine on the expected SUDEP mortality rates in patients with Dravet syndromeJ Helen Cross, Bradley S Galer, Antonio Gil-Nagel, et al.
Pageof 6